We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Ultracompact Real-time PCR System Ready for Worldwide Distribution

By LabMedica International staff writers
Posted on 13 Jul 2011
A state-of-the-art real-time PCR system featuring leading edge thermal resolution and reproducibility packed into an incredibly small platform has been introduced into the biotech market.

The LightCycler Nano Real-Time PCR System is the product of an exclusive OEM agreement between Roche Applied Science (Basel, Switzerland) and IT-IS Life Sciences Ltd. More...
(Stokesley, United Kingdom). The system uses proprietary Roche dyes and reagents for precise and reproducible DNA amplification and melting curve analysis.

The LightCycler Nano is a 32-well format real-time PCR cycler with state of the art functionality and easy-to-use software. As it is both silent and compact, this instrument was designed to be an excellent bench-top companion for laboratory end users performing real-time PCR on a daily basis. The system uses convenient, standard PCR strips and can support all common detection dyes with its full spectrum optics.

Roche is the world’s largest biotech company with over 80,000 employees and more than nine billion Swiss francs committed to research and development. Regarding the new LightCycler Nano Instrument, Roche’s head of PCR projects, Gerd Haberhausen, said, Like all LightCycler Real-Time PCR Instruments, the LightCycler Nano Real-Time PCR Instrument produces high quality qPCR, genotyping and high resolution melting data using easy-fit reagents, reaction vessels, and instrumentation. The LightCycler Nano Real-Time PCR System was built to enjoy in every lab, on every bench - serious PCR and fun!”

Roderic Fuerst, CEO of IT-IS Life Sciences Ltd., said, “We believe that the creative engineering capability of IT-IS and the market leadership position of Roche in real-time PCR are a perfect match for each other. The LightCycler Nano system will deliver exceptional performance, ease of use, and value due to its highly integrated solid-state design.”

Related Links:
Roche Applied Science
IT-IS Life Sciences Ltd.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.